- Home
- OCC vs CALC Comparison
OCC vs CALC Comparison
Compare OCC & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCC
- CALC
- Stock Information
- Founded
- OCC 1983
- CALC 2011
- Country
- OCC United States
- CALC United States
- Employees
- OCC N/A
- CALC N/A
- Industry
- OCC Telecommunications Equipment
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- OCC Industrials
- CALC Health Care
- Exchange
- OCC Nasdaq
- CALC Nasdaq
- Market Cap
- OCC 23.4M
- CALC 20.9M
- IPO Year
- OCC 1996
- CALC N/A
- Fundamental
- Price
- OCC $3.20
- CALC $2.07
- Analyst Decision
- OCC
- CALC Strong Buy
- Analyst Count
- OCC 0
- CALC 3
- Target Price
- OCC N/A
- CALC $16.33
- AVG Volume (30 Days)
- OCC 11.8K
- CALC 28.2K
- Earning Date
- OCC 06-09-2025
- CALC 05-20-2025
- Dividend Yield
- OCC N/A
- CALC N/A
- EPS Growth
- OCC N/A
- CALC N/A
- EPS
- OCC N/A
- CALC N/A
- Revenue
- OCC $67,561,951.00
- CALC N/A
- Revenue This Year
- OCC N/A
- CALC N/A
- Revenue Next Year
- OCC N/A
- CALC N/A
- P/E Ratio
- OCC N/A
- CALC N/A
- Revenue Growth
- OCC N/A
- CALC N/A
- 52 Week Low
- OCC $2.02
- CALC $1.43
- 52 Week High
- OCC $7.00
- CALC $6.02
- Technical
- Relative Strength Index (RSI)
- OCC 50.12
- CALC 69.21
- Support Level
- OCC $3.06
- CALC $1.52
- Resistance Level
- OCC $3.28
- CALC $2.15
- Average True Range (ATR)
- OCC 0.19
- CALC 0.13
- MACD
- OCC 0.05
- CALC 0.08
- Stochastic Oscillator
- OCC 53.23
- CALC 88.89
About OCC Optical Cable Corporation
Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, renewable energy and broadcast applications, and for the wireless carrier market.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.